GSK buys into S Korea's top pharma firm as part of promotional alliance
This article was originally published in Scrip
Executive Summary
GlaxoSmithKline has acquired a roughly 10% stake in South Korea's largest pharmaceutical firm, Dong-A Pharmaceuticals, as part of a commercial alliance for selected products in the country.